Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-κβ pathway

Abstract

Background Chronic hyperammonemia induces neuroinflammation in cerebellum, with glial activation and enhanced activation of the TNFR1-NF-kB-glutaminase-glutamate-GABA pathway. Hyperammonemia also increases glycinergic neurotransmission. These alterations contribute to cognitive and motor impairment. Activation of glycine receptors is reduced by extracellular cGMP, which levels are reduced in cerebellum of hyperammonemic rats in vivo. We hypothesized that enhanced glycinergic neurotransmission in hyperammonemic rats (1) contributes to induce neuroinflammation and glutamatergic and GABAergic neurotransmission alterations; (2) is a consequence of the reduced extracellular cGMP levels. The aims were to assess, in cerebellum of hyperammonemic rats, (a) whether blocking glycine receptors with the antagonist strychnine reduces neuroinflammation; (b) the cellular localization of glycine receptor; (c) the effects of blocking glycine receptors on the TNFR1-NF-kB-glutaminase-glutamate-GABA pathway and microglia activation; (d) whether adding extracellular cGMP reproduces the effects of strychnine. Methods We analyzed in freshly isolated cerebellar slices from control or hyperammonemic rats the effects of strychnine on activation of microglia and astrocytes, the content of TNFa and IL1b, the surface expression of ADAM17, TNFR1 and transporters, the phosphorylation levels of ERK, p38 and ADAM17. The cellular localization of glycine receptor was assessed by immunofluorescence. We analyzed the content of TNFa, IL1b, HMGB1, glutaminase, and the level of TNF-a mRNA and NF-κB in Purkinje neurons. Extracellular concentrations of glutamate and GABA were performed by in vivo microdialysis in cerebellum. We tested whether extracellular cGMP reproduces the effects of strychnine in ex vivo cerebellar slices. Results Glycine receptors are expressed mainly in Purkinje cells. In hyperammonemic rats, enhanced glycinergic neurotransmission leads to reduced membrane expression of ADAM17, resulting in increased surface expression and activation of TNFR1 and of the associated NF-kB pathway. This increases the expression in Purkinje neurons of TNFa, IL-1b, HMGB1, and glutaminase. Increased glutaminase activity leads to increased extracellular glutamate, which increases extracellular GABA. Increased extracellular glutamate and HMGB1 potentiate microglial activation. Blocking glycine receptors with strychnine or extracellular cGMP completely prevents the above pathway in hyperammonemic rats. Conclusions Glycinergic neurotransmission modulates neuroinflammation. Enhanced glycinergic neurotransmission in hyperammonemia would be due to reduced extracellular cGMP. These results shed some light on possible new therapeutic target pathways for pathologies associated to neuroinflammation.

Pregnenolone Attenuates the Ischemia-Induced Neurological Deficit in the Transient Middle Cerebral Artery Occlusion Model of Rats

“… 18 , 19 P5 has been effective in enhancing the release of acetylcholine and increases the spatial memory in rats. 20 , 21 To confirm that infarct volume is a measure of how serious the ischemia damage is, TTC staining was utilized, which accurately identifies the infarct volume. Because of ischemia, the rats given tMCAO had a considerable amount of lesioned regions.…”

Nalbuphine Alleviates Inflammation by Down-regulating NF-κB in an Acute Inflammatory Visceral Pain Rat Model

“…Usually, NF-κB couples with IκBα in an inactive state in cells, and when the synthesis of IκBa is inhibited or decomposed, NF-κB activation increases [52]. IκBα as a key inhibitory protein of NF-κB inhibits the activation of NF-κB (p65) and then reduces expression of downstream pro-in ammatory factors like TNF-α [53,54]. In the present study, visceral pain caused by acetic acid (i.p) could increase the expression of NF-κB (p65) and TNF-α, whereas decreased the level of IκBα in the spinal cord, especially in the macrophage/microglia at white matter of the spinal cord.…”

Nalbuphine alleviates inflammation by down-regulating NF-κB in an acute inflammatory visceral pain rat model

“…Usually, NF-κB couples with IκBα in an inactive state in cells, and when the synthesis of IκBa is inhibited or decomposed, NF-κB activation increases [ 58 ]. IκBα as a key inhibitory protein of NF-κB inhibits the activation of NF-κB (p65) and then reduces expression of downstream pro-inflammatory factors like TNF-α [ 59 , 60 ]. In the present study, visceral pain caused by acetic acid (i.p) could increase the expression of NF-κB (p65) and TNF-α, whereas decreased the level of IκBα in the spinal cord, especially in the macrophage/microglia at white matter of the spinal cord.…”